The European Consortium for Continuous Pharmaceutical Manufacturing (ECCPM) was founded to address the challenges of transferring continuous manufacturing (CM) concepts from research and development to production scale.
The consortium serves as a platform for companies and academic institutions to share knowledge and best practices, and develop a collective vision on CM. We do this through regular, pre-competitive workshops and forums where we address the challenges we face when implementing a CM process or a product development process based on CM.
To define the contextualization of CM within the pharmaceutical industry, we have chosen a practical “use cases” approach that focuses on the investigation, development and implementation of continuous manufacturing strategies – from API synthesis, and downstreaming to the final dosage form.
The knowledge and issues generated out of the use cases set the direction for the theme definition of the yearly ECCPM Forum. The Forum is open to attendees from all pharmaceutical organizations and features key note lectures on relevant industrial and scientific topics.
The information in each news release posted on this page was factually accurate on the date it was issued. The consortium assumes no duty to update the information to reflect subsequent developments.